Evidence map›Paper›PMID 29532016›Full record

ArticleACS central science2018

Conditional and Reversible Activation of Class A and B G Protein-Coupled Receptors Using Tethered Pharmacology.

Tom Podewin, Julia Ast, Johannes Broichhagen, Nicholas H F Fine, Daniela Nasteska, Philipp Leippe, Manuel Gailer, Teresa Buenaventura, Nisha Kanda, Ben J Jones and 7 more

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Prolonged signaling of backbone-modified glucagon-like peptide-Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. The therapeutic potential of GLP-1 receptor biased agonism.British journal of pharmacology · 2022 · on this map
    Review
  10. Review
  11. Article
  12. Controlling Site-Directed RNA Editing by Chemically Induced Dimerization.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  13. Article
  14. Interrogating surfaceChemical science · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Tom PodewinDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, 81377 Munich, Germany.
Julia AstInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, B15 2TT, Birmingham, United Kingdom.
Johannes BroichhagenDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, 81377 Munich, Germany.
Nicholas H F FineInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, B15 2TT, Birmingham, United Kingdom.
Daniela NasteskaInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, B15 2TT, Birmingham, United Kingdom.
Philipp LeippeDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, 81377 Munich, Germany.
Manuel GailerDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, 81377 Munich, Germany.
Teresa BuenaventuraSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
Nisha KandaSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
Ben J JonesSection of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, W12 0NN, United Kingdom.
Celine M'KadmiInstitut des Biomolécules Max Mousseron, UMR 5247 CNRS-Université Montpellier-ENSCM, Faculté de Pharmacie, 15 Avenue Charles Flahault, BP 14491, 34093 Montpellier Cedex 05, France.
Jean-Louis BaneresInstitut des Biomolécules Max Mousseron, UMR 5247 CNRS-Université Montpellier-ENSCM, Faculté de Pharmacie, 15 Avenue Charles Flahault, BP 14491, 34093 Montpellier Cedex 05, France.
Jacky MarieInstitut des Biomolécules Max Mousseron, UMR 5247 CNRS-Université Montpellier-ENSCM, Faculté de Pharmacie, 15 Avenue Charles Flahault, BP 14491, 34093 Montpellier Cedex 05, France.
Alejandra TomasSection of Cell Biology and Functional Genomics, Department of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
Dirk TraunerDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, 81377 Munich, Germany.
Anja Hoffmann-RöderDepartment of Chemistry and Center for Integrated Protein Science, LMU Munich, 81377 Munich, Germany.
David J HodsonInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, B15 2TT, Birmingham, United Kingdom.
Center for Integrated Protein Science Munich · DEUniversity of Nottingham · GBÉcole Nationale Supérieure de Chimie de Montpellier · FRGenomics (United Kingdom) · GBImperial College London · GB

Funding

Diabetes UK 12/0004431Medical Research Council MR/K023667/1Medical Research Council MR/M012646/1Medical Research Council MR/N00275X/1Wellcome Trust
6 · The paper itself

Abstract

Understanding the activation and internalization of G protein-coupled receptors (GPCRs) using conditional approaches is paramount to developing new therapeutic strategies. Here, we describe the design, synthesis, and testing of

Identifiers

PMID29532016
PMCPMC5832994
OpenAlexW2783220867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.